{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:06:56Z","timestamp":1794492416711,"version":"4.9.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Emergency Medicine Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.emc.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:34:02Z","timestamp":1649118842000},"page":"265-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Emerging Agents of Substance Use\/Misuse"],"prefix":"10.1016","volume":"40","author":[{"given":"Avery E.","family":"Michienzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Borek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.emc.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fpsyt.2017.00152","article-title":"Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs","volume":"8","author":"Hassan","year":"2017","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.emc.2022.01.001_bib5","series-title":"Goldfrank\u2019s Toxicologic Emergencies","first-page":"1111","article-title":"Cannabinoids McGraw Hill Medical","author":"Lapoint","year":"2019"},{"key":"10.1016\/j.emc.2022.01.001_bib6","first-page":"17","article-title":"What Is the Farm Bill?","author":"Johnson","year":"2019","journal-title":"Congr Res Serv"},{"key":"10.1016\/j.emc.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fpls.2019.00697","article-title":"Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States","volume":"10","author":"Mead","year":"2019","journal-title":"Front Plant Sci"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New trends in cannabis potency in USA and Europe during the last decade (2008-2017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.emc.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13556210500123217","article-title":"Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops","volume":"10","author":"Pijlman","year":"2005","journal-title":"Addict Biol"},{"issue":"5","key":"10.1016\/j.emc.2022.01.001_bib10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1556-4029.2010.01441.x","article-title":"Potency trends of \u03949-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008","volume":"55","author":"Mehmedic","year":"2010","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.emc.2022.01.001_bib11","series-title":"Marijuana potency","year":"2021"},{"key":"10.1016\/j.emc.2022.01.001_bib12","author":"Drug Enforcement Administration"},{"key":"10.1016\/j.emc.2022.01.001_bib13","author":"Drug Enforcement Administration"},{"key":"10.1016\/j.emc.2022.01.001_bib16","author":"Ritchel"},{"key":"10.1016\/j.emc.2022.01.001_bib17","author":"Sullivan"},{"key":"10.1016\/j.emc.2022.01.001_bib18","author":"McKenzie"},{"key":"10.1016\/j.emc.2022.01.001_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/SAR.S73586","article-title":"Emerging drugs of abuse: current perspectives on synthetic cannabinoids","volume":"6","author":"Debruyne","year":"2015","journal-title":"Subst Abuse Rehabil"},{"issue":"2","key":"10.1016\/j.emc.2022.01.001_bib20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cpt.563","article-title":"Focus on cannabinoids and synthetic cannabinoids","volume":"101","author":"Le Boisselier","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.emc.2022.01.001_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/15563650.2018.1548708","article-title":"Acute cannabis toxicity","volume":"57","author":"Noble","year":"2019","journal-title":"Clin Toxicol Phila Pa"},{"key":"10.1016\/j.emc.2022.01.001_bib22","series-title":"StatPearls","article-title":"Marijuana Toxicity","author":"Turner","year":"2021"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib23","first-page":"1","article-title":"An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions","volume":"5","author":"Crean","year":"2011","journal-title":"J\u00a0Addict Med"},{"issue":"5","key":"10.1016\/j.emc.2022.01.001_bib24","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis","volume":"42","author":"Marconi","year":"2016","journal-title":"Schizophr Bull"},{"issue":"6","key":"10.1016\/j.emc.2022.01.001_bib25","first-page":"598","article-title":"Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review","volume":"24","author":"Courts","year":"2016","journal-title":"Australas Psychiatry Bull R Aust N Z Coll Psychiatr"},{"issue":"7","key":"10.1016\/j.emc.2022.01.001_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.8516","article-title":"Critical Illness Secondary to Synthetic Cannabinoid Ingestion","volume":"3","author":"Kourouni","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.emc.2022.01.001_bib27","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.annemergmed.2020.08.021","article-title":"Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial","volume":"77","author":"Ruberto","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"3","key":"10.1016\/j.emc.2022.01.001_bib28","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00213-018-5066-6","article-title":"Synthetic cathinone adulteration of illegal drugs","volume":"236","author":"Oliver","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.emc.2022.01.001_bib29","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/ja01395a032","article-title":"Sythetic Homologs of d,l-Ephedrirne","volume":"50","author":"Hyde","year":"1928","journal-title":"J\u00a0Am Chem Soc"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic cathinones: a new public health problem","volume":"13","author":"Karila","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.emc.2022.01.001_bib32","series-title":"Synthetic cathinones (\u201cBath salts\u201d) DrugFacts","year":"2020"},{"key":"10.1016\/j.emc.2022.01.001_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2016.02.001","article-title":"Detection of \u201cbath salts\u201d and other novel psychoactive substances in hair samples of ecstasy\/MDMA\/\"Molly\" users","volume":"161","author":"Palamar","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.emc.2022.01.001_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2017.07.010","article-title":"Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene","volume":"48","author":"Palamar","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.emc.2022.01.001_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annemergmed.2012.01.005","article-title":"Hyperthermia and multiorgan failure after abuse of \u201cbath salts\u201d containing 3,4-methylenedioxypyrovalerone","volume":"60","author":"Borek","year":"2012","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.emc.2022.01.001_bib37","author":"Memmott"},{"issue":"Pt A","key":"10.1016\/j.emc.2022.01.001_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.emc.2022.01.001_bib42","author":"Drug Enforcement Administration"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12630-019-01294-y","article-title":"Carfentanil: a narrative review of its pharmacology and public health concerns","volume":"66","author":"Leen","year":"2019","journal-title":"Can J Anaesth J Can Anesth"},{"issue":"2","key":"10.1016\/j.emc.2022.01.001_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/jpet.119.258566","article-title":"Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis","volume":"371","author":"Torralva","year":"2019","journal-title":"J\u00a0Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s13181-020-00785-5","article-title":"Opioid-Associated Hearing Loss: A 20-Year Review from the New Jersey Poison Center","volume":"16","author":"Mozeika","year":"2020","journal-title":"J\u00a0Med Toxicol Off J Am Coll Med Toxicol"},{"issue":"2","key":"10.1016\/j.emc.2022.01.001_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J\u00a0Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15563650.2018.1510502","article-title":"Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017","volume":"57","author":"Carpenter","year":"2019","journal-title":"Clin Toxicol Phila Pa"},{"key":"10.1016\/j.emc.2022.01.001_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances\u2014designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"NeuroToxicol"},{"issue":"10","key":"10.1016\/j.emc.2022.01.001_bib49","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse Effects From Counterfeit Alprazolam Tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40122-020-00151-x","article-title":"Kratom-Pharmacology, Clinical Implications, and Outlook: A Comprehensive Review","volume":"9","author":"Eastlack","year":"2020","journal-title":"Pain Ther"},{"key":"10.1016\/j.emc.2022.01.001_bib51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2019.05.003","article-title":"Kratom policy: The challenge of balancing therapeutic potential with public safety","volume":"70","author":"Prozialeck","year":"2019","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib52","article-title":"Kratom (Mitragyna speciosa): Friend or Foe?","volume":"22","author":"Sethi","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.emc.2022.01.001_bib53","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm6814a2","article-title":"Notes from the Field: Unintentional Drug Overdose Deaths with Kratom Detected \u2014 27 States, July 2016\u2013December 2017","volume":"68","author":"Olsen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.emc.2022.01.001_bib54","article-title":"FDA In Brief: FDA releases test results identifying dangerous levels of heavy metals in certain kratom products","year":"2019","journal-title":"FDA"},{"key":"10.1016\/j.emc.2022.01.001_bib55","article-title":"FDA. Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner for Foods and Veterinary Medicine Stephen Ostroff, M.D., on the ongoing risk of salmonella in kratom products","year":"2020","journal-title":"FDA"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib56","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/anatox\/35.4.242","article-title":"Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton","volume":"35","author":"Kronstrand","year":"2011","journal-title":"J\u00a0Anal Toxicol"},{"issue":"18","key":"10.1016\/j.emc.2022.01.001_bib57","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1021\/acs.jmedchem.6b00748","article-title":"Mitragynine\/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit \u03b2-Arrestin-2","volume":"59","author":"V\u00e1radi","year":"2016","journal-title":"J\u00a0Med Chem"},{"issue":"7","key":"10.1016\/j.emc.2022.01.001_bib58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/phar.2280","article-title":"Kratom Use and Toxicities in the United States","volume":"39","author":"Eggleston","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.emc.2022.01.001_bib59","first-page":"24","article-title":"Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal","volume":"3","author":"Overbeek","year":"2019","journal-title":"Clin Pract Cases Emerg Med"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-019-1009-0","article-title":"Phenibut (\u03b2-Phenyl-\u03b3-Aminobutyric Acid): an Easily Obtainable \u201cDietary Supplement\u201d With Propensities for Physical Dependence and Addiction","volume":"21","author":"Jouney","year":"2019","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1527-3458.2001.tb00211.x","article-title":"Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug","volume":"7","author":"Lapin","year":"2001","journal-title":"CNS Drug Rev"},{"issue":"35","key":"10.1016\/j.emc.2022.01.001_bib62","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.15585\/mmwr.mm6935a5","article-title":"Notes from the Field: Phenibut Exposures Reported to Poison Centers - United States, 2009-2019","volume":"69","author":"Graves","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.emc.2022.01.001_bib63","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/dar.12356","article-title":"Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity","volume":"35","author":"Owen","year":"2016","journal-title":"Drug Alcohol Rev"},{"issue":"2","key":"10.1016\/j.emc.2022.01.001_bib64","first-page":"125","article-title":"Acute phenibut withdrawal: A comprehensive literature review and illustrative case report","volume":"19","author":"Hardman","year":"2019","journal-title":"Bosn J Basic Med Sci"},{"issue":"5","key":"10.1016\/j.emc.2022.01.001_bib65","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/JCP.0000000000001104","article-title":"Detoxification of a Patient With Comorbid Dependence on Phenibut and Benzodiazepines by Tapering With Baclofen: Case Report","volume":"39","author":"Coenen","year":"2019","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.emc.2022.01.001_bib66","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-008381","article-title":"Phenibut dependence","volume":"2013","author":"Samokhvalov","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.emc.2022.01.001_bib67","author":"Zahran"},{"issue":"2","key":"10.1016\/j.emc.2022.01.001_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/15563650.2020.1781151","article-title":"Characteristics of tianeptine effects reported to a poison control center: a growing threat to public health","volume":"59","author":"Rushton","year":"2021","journal-title":"Clin Toxicol Phila Pa"},{"key":"10.1016\/j.emc.2022.01.001_bib70","author":"Glenn"},{"key":"10.1016\/j.emc.2022.01.001_bib71","article-title":"Nutrition C for FS and A. Tianeptine in Dietary Supplements","year":"2020","journal-title":"FDA"},{"issue":"6","key":"10.1016\/j.emc.2022.01.001_bib72","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.psym.2018.07.006","article-title":"Tianeptine Abuse and Dependence: Case Report and Literature Review","volume":"59","author":"Lauhan","year":"2018","journal-title":"Psychosomatics"},{"issue":"12","key":"10.1016\/j.emc.2022.01.001_bib73","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1038\/npp.2012.135","article-title":"The same antidepressant elicits contrasting patterns of synaptic changes in the amygdala vs hippocampus","volume":"37","author":"Pillai","year":"2012","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.emc.2022.01.001_bib74","first-page":"331","article-title":"Use of Buprenorphine-Naloxone in the Treatment of Tianeptine Use Disorder","volume":"13","author":"Trowbridge","year":"2019","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.emc.2022.01.001_bib77","author":"Craven"}],"container-title":["Emergency Medicine Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862722000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733862722000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:39:08Z","timestamp":1760006348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733862722000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0733862722000013"],"URL":"https:\/\/doi.org\/10.1016\/j.emc.2022.01.001","relation":{},"ISSN":["0733-8627"],"issn-type":[{"value":"0733-8627","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Agents of Substance Use\/Misuse","name":"articletitle","label":"Article Title"},{"value":"Emergency Medicine Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.emc.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}